Analysts Offer Insights on Healthcare Companies: ConforMIS (NASDAQ: CFMS), Amgen Inc (NASDAQ: AMGN) and Dexcom (NASDAQ: DXCM)

By Ryan Adsit

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ConforMIS (NASDAQ: CFMS), Amgen Inc (NASDAQ: AMGN) and Dexcom (NASDAQ: DXCM).

ConforMIS (NASDAQ: CFMS)

In a report released yesterday, Ryan Zimmerman from BTIG assigned a Buy rating to ConforMIS (NASDAQ: CFMS), with a price target of $4. The company’s shares closed yesterday at $2.59, close to its 52-week low of $2.21.

According to TipRanks.com, Zimmerman is a 4-star analyst with an average return of 14.4% and a 64.0% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, OrthoPediatrics Corp, and SeaSpine Holdings.

ConforMIS has an analyst consensus of Moderate Buy, with a price target consensus of $5.

Amgen Inc (NASDAQ: AMGN)

J.P. Morgan analyst Cory Kasimov assigned a Hold rating to Amgen Inc (NASDAQ: AMGN) yesterday. The company’s shares closed yesterday at $183.38.

According to TipRanks.com, Kasimov is a 4-star analyst with an average return of 4.9% and a 39.8% success rate. Kasimov covers the Healthcare sector, focusing on stocks such as ACADIA Pharmaceuticals Inc, Ionis Pharmaceuticals Inc, and Global Blood Therapeutics.

Amgen Inc has an analyst consensus of Moderate Buy, with a price target consensus of $194.57.

Dexcom (NASDAQ: DXCM)

BTIG analyst Sean Lavin assigned a Hold rating to Dexcom (NASDAQ: DXCM) yesterday. The company’s shares closed yesterday at $54.60.

According to TipRanks.com, Lavin is a 5-star analyst with an average return of 16.1% and a 63.6% success rate. Lavin covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Obalon Therapeutics Inc, and Varian Medical Systems.

Currently, the analyst consensus on Dexcom is Moderate Buy and the average price target is $63.50, representing a 16.3% upside.

In a report issued on January 4, Robert W. Baird also maintained a Hold rating on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.